<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>parkinson | LifeTein Peptide Blog</title>
	<atom:link href="https://www.lifetein.com/blog/tag/parkinson/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.lifetein.com/blog</link>
	<description>LifeTein: Custom Peptide Synthesis Service</description>
	<lastBuildDate>Sun, 17 Nov 2024 03:28:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.lifetein.com/blog/wp-content/uploads/2023/10/cropped-android-chrome-512x512-1-32x32.png</url>
	<title>parkinson | LifeTein Peptide Blog</title>
	<link>https://www.lifetein.com/blog</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Peptides for Parkinson&#8217;s disease (PD)</title>
		<link>https://www.lifetein.com/blog/peptides-for-parkinsons-disease-pd/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=peptides-for-parkinsons-disease-pd</link>
		
		<dc:creator><![CDATA[LifeTein Peptide]]></dc:creator>
		<pubDate>Thu, 14 Jan 2016 16:18:01 +0000</pubDate>
				<category><![CDATA[Peptide]]></category>
		<category><![CDATA[amyloid]]></category>
		<category><![CDATA[parkinson]]></category>
		<category><![CDATA[peptide synthesis]]></category>
		<guid isPermaLink="false">http://www.lifetein.com/blog/?p=300</guid>

					<description><![CDATA[<p>LifeTein synthesized all peptides used in this study for Parkinson&#8217;s disease. α-synuclein is an indication of the pathogenesis of Parkinson&#8217;s disease. It was found that a molecular mimicry mechanism between HSV1 and human α-synuclein could trigger PD.</p>
The post <a href="https://www.lifetein.com/blog/peptides-for-parkinsons-disease-pd/">Peptides for Parkinson’s disease (PD)</a> first appeared on <a href="https://www.lifetein.com/blog">LifeTein Peptide Blog</a>.]]></description>
										<content:encoded><![CDATA[<p>LifeTein synthesized all peptides used in this study for Parkinson&#8217;s disease. α-synuclein is an indication of the pathogenesis of Parkinson&#8217;s disease. It was found that a molecular mimicry mechanism between HSV1 and human α-synuclein could trigger PD.</p>


<p class="has-text-align-center wp-block-paragraph"></p>



<p class="wp-block-paragraph"></p>The post <a href="https://www.lifetein.com/blog/peptides-for-parkinsons-disease-pd/">Peptides for Parkinson’s disease (PD)</a> first appeared on <a href="https://www.lifetein.com/blog">LifeTein Peptide Blog</a>.]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/?utm_source=w3tc&utm_medium=footer_comment&utm_campaign=free_plugin


Served from: www.lifetein.com @ 2026-04-14 14:29:28 by W3 Total Cache
-->